Facultad De Medicina

 INICIO: PRECOZ.-¿Desde cuándo noto usted que eyaculaba antes de realizar la penetración sexual en su pareja, o segundos después de la penetración? RETARDADA.-¿Desde cuándo noto su dificultad para eyacular? ANAEYACULACIÓN.-¿Desde cuándo noto que no eyacula?  PERIODOS: PRECOZ/RETARDADA/ANAEYACUALACIÓN.-¿Cada cuando se presenta? ¿Continuamente o esporádicamente?  PRESENTACIÓN: PRECOZ.-¿Se presenta esta eyaculación antes de la penetración o durante la penetración?  AGRAVANTES: PRECOZ.-¿Hay algo que aumente que eyacule antes de la penetración o después de esta? RETARDADA.-¿Existe algo que aumente su dificultad para eyacular? ANAEYACULACIÓN.-¿Existe algo con lo que note que no eyacula?  ATENUANTES: PRECOZ.-¿Hay algo que disminuya su eyaculación antes de la penetración o después de esta? RETARDADA.-¿Existe algo que disminuya su dificultad para eyacular? ANAEYACULACIÓN.-¿Existe algo con lo que disminuya su falta de eyaculación?  SINTOMAS ASOCIADOS: ¿Ha presentado alguna otra molestia?

Objective: There is accumulated evidence that mesial temporal lobe seizures are preceded by a preictal transition that evolves over minutes to hours. In the present study, we investigated these possible preictal changes in long-term intracranial recordings of five patients by a measure of phase synchronization. In order to clearly distinguish preictal changes from all the other interictal states, we developed an automatic extraction of representative patterns of interictal synchronization activity. This reference library was used to classify the successive synchronization patterns of long-term recordings into groups of similar patterns. Altered states of brain synchronization were identified as deviating from patterns in the reference library and were evaluated relative to the times of seizure onset in terms of sensitivity and specificity.

Vale para guía de examen Examen de Selección Imprime esta página para canjearla por tu guía de examen a partir del día: 24 de febrero de 2014 Núm de control: 465510 Nombre: MARTINEZ VILCHIS BLANCA ESTHELA LICENCIATURA DE MEDICO CIRUJANO Tipo de guía : Exani II Fecha de impresión:

Background Adequate enteral nutrition may be difficult to achieve early in neonates after cardiac surgery, but it is essential for growth, wound healing, and immune function. Objective To assess caloric intake in neonates receiving enteral nutrition after surgery. Methods A retrospective chart review was conducted of daily enteral caloric intake in the cardiac intensive care unit of a tertiary children's hospital. Data on the institution of enteral feeding and the discontinuation of parenteral nutrition were assessed for full-term neonates who had undergone cardiac surgery. Results Caloric intake was assessed in 100 patients, 52 with biventricular cardiac defects and 48 with a functional single ventricle. The median duration of stay in the cardiac intensive care unit was 13 days (range, 4-69), and patients received enteral feeding exclusively for a median of 5 days (range, 1-43). In total, 705 patient days were evaluated. The median caloric intake per day was 93 kcal/kg (range, 43-142). A goal of 100 kcal/kg was achieved for 48.4% of patient days and 120 kcal/kg for only 19.7% of patient days. Median weight change for the period of enteral feeding was -20 g (range, -775 to 1485 g). Conclusions Enteral feeding alone is often suboptimal after neonatal cardiac surgery. New strategies to improve caloric intake may enhance postoperative recovery.

Las enfermedades causadas por parásitos son un enorme problema en el mundo entero porque afectan a un gran número de individuos. Se estima que hay mil millones de personas infectadas con parásitos en todo el mundo. La mayoría de estas personas viven en países subdesarrollados en los cuales el elevado costo de la salud es el factor que decide si el paciente será o no tratado. La incidencia de algunas enfermedades parasitarias es del 80 % de la población. El alto costo del descubrimiento de nuevas drogas y la baja incidencia de algunas enfermedades parasitarias en países desarrollados lleva al bajo interés de las industrias farmacéuticas por ambos: estudio de nuevos compuestos activos y desarrollo de nuevas terapias para combatir este tipo de enfermedades.

Borrelia burgdorferi is highly susceptible to antibiotic treatment and the majority of patients proMt from this treatment. Antibiotic selection, dose and route of administration, and duration of therapy for Lyme disease depend on the patient's clinical manifestations and stage of disease, age, pregnancy status, as well as the presence of other concomitant diseases and/or allergies. Despite an appropriate antibiotic therapy, about 10-20% of patients may show… 1st Giusto Trevisan Abstract: Borrelia burgdorferi is highly susceptible to antibiotic treatment and the majority of patients profit from this treatment. Antibiotic selection, dose and route of administration, and duration of therapy for Lyme disease depend on the patient's clinical manifestations and stage of disease, age, pregnancy status, as well as the presence of other concomitant diseases and/or allergies. Despite an appropriate antibiotic therapy, about 10-20% of patients may show persistent or recurrent symptoms ("post-treatment Lyme disease syndrome"). In the present paper we will briefly discuss the post-exposure prophylaxis, before going on to talk over the current therapeutic approach regarding the management of Lyme disease according to the stage of disease/clinical manifestations. Finally, we will discuss the main treatment-related phenomenon, the Jarisch-Herxheimer reaction, and the treatment modalities for special categories of patients, namely pregnant women, subjects suffering from post-treatment Lyme disease syndrome, possible Borrelia-associated skin manifestations, coinfections and Baggio-Yoshinary syndrome.